Aarti Pharmalabs Limited Cash Flow-to-Debt Ratio
Aarti Pharmalabs Limited cash flow-to-debt ratio. Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2023, meaning its operating cash flow of Rs362.80 Million could theoretically repay 0% of its total liabilities (Rs6.56 Billion) in one year. Check Aarti Pharmalabs Limited earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aarti Pharmalabs Limited (2020–2025)
Cash flow-to-debt ratio of Aarti Pharmalabs Limited from 2020 to 2025. Historical debt coverage capacity for Aarti Pharmalabs Limited across 6 annual periods. Check Aarti Pharmalabs Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Aarti Pharmalabs Limited Cash Flow-to-Debt Ratio by Year (2020–2025)
Aarti Pharmalabs Limited cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Aarti Pharmalabs Limited. For the full cash flow conversion analysis, see AARTIPHARM cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | Rs3.32 Billion | Rs9.16 Billion | ▲ +38.0% |
| 2024 | 0.26x | Rs2.16 Billion | Rs8.25 Billion | ▼ -31.6% |
| 2023 | 0.38x | Rs2.63 Billion | Rs6.86 Billion | ▲ +673.6% |
| 2022 | -0.07x | Rs-437.04 Million | Rs6.53 Billion | — |
| 2021 | 0.00x | Rs0.00 | Rs232.71K | ▲ +100.0% |
| 2020 | -1.00x | Rs-186.75K | Rs186.75K | — |